Panaxia Is Preparing for European Sales: Announces an Agreement for Temporary Use Rights in an R&D Facility in Malta for the Commercial Production and Marketing of Its European Cannabis Products in Europe

Pharmaceutical company Panaxia Labs Israel Ltd. (Panaxia Israel) (TASE: PNAX), the largest manufacturer of medical cannabis products in Israel, announced today its contractual agreement with the…

Pharmaceutical company Panaxia Labs Israel Ltd. (Panaxia Israel) (TASE: PNAX), the largest manufacturer of medical cannabis products in Israel, announced today its contractual agreement with the holder of controlling interest, Panaxia Pharmaceutical Industries, to use the research and development of the holder of controlling interest in Malta for the production and extraction the company’s advanced products […]

The post Panaxia Is Preparing for European Sales: Announces an Agreement for Temporary Use Rights in an R&D Facility in Malta for the Commercial Production and Marketing of Its European Cannabis Products in Europe appeared first on Technical420.

Leave a Reply

Your email address will not be published. Required fields are marked *